Bharat Biotech’s chikungunya vaccine enters phase I clinical trials
The placebo controlled study involving 60 healthy volunteers would test escalating doses of the vaccine in prime-boost regimen
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.